Accuray develops, manufactures and sells radiotherapy systems that make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives.
We are in this fight together
Accuray technologies empower treatment teams around the world to transform the fight against cancer — improving clinical and economic outcomes through a singular focus on making cancer treatment as precise as possible for every patient. Accuray is listed on the NASDAQ Stock Exchange as ARAY.
Confidently delivering effective treatments with minimal side effects.
Making personalized treatments practical for every patient, every day.
Delivering fewer, faster and more comfortable treatments cost-effectively.
Our vision and mission
We work passionately to create a future without the fear, pain or human suffering of cancer. We pursue this by developing precise, innovative tumor treatment solutions that empower clinicians and help cancer patients live longer, better lives.
Innovating patient-first cancer treatment
It’s not just a tagline. It’s who we are, what we do and what makes us different. Throughout our history, we’ve continually introduced important cancer treatment breakthroughs that improve outcomes for patients and enhancing quality of life through treatment and into survivorship. We carry that momentum forward today, fully invested in redefining the future of cancer care. Because we believe every patient deserves the best possible treatment.
A legacy of patient-first innovation
People we serve
Offering new hope to cancer patients through innovations that help them return to their lives sooner — healthier.
Giving treatment teams the tools to confidently improve the lives of patients, create empowered work environments and build strong, profitable practices.
Providing rewarding growth opportunities through a highly differentiated portfolio of radiosurgery and radiotherapy systems — and relentless investment in developing new technologies.
Creating an environment that promotes collaboration and innovation to continually elevate the standard of care for cancer patients worldwide.
Hong Kong, China
900 Colleagues globally
Listed as ARAY
Connect with Accuray to get the answers you need.